Jinxin Fertility (锦欣生殖) Placement - Setting up for Acquisitions
Jinxin Fertility Co Ltd (1951 HK) is looking to raise US$167m in its top-up placement to fund potential acquisitions in China and Southeast Asia.
638 Views
Suzhou Basecare Medical IPO Initiation: Improving IVF
Basecare is pre-marketing for an HK IPO to raise $250 million. With a large addressable market opportunity and Basecare’s early mover advantage, we...
623 Views
Jinxin Fertility (锦欣生殖) Placement - Only Warburg Selling This Time
Amethyst Gem (Warburg Pincus) is looking to sell 80m shares in Jinxin Fertility Co Ltd (1951 HK). Post selldown, Amethyst Gem will still have...
461 Views
Jinxin Fertility Placement: Sound Fundamentals
3 shareholders of Jinxin Fertility come to market to sell 207.6 million shares. In this note, we will provide our thoughts on the deal. We like the...
593 Views
Hygeia Healthcare (海吉亚) IPO Trading: Upside Might Take Time to Crystalize
Hygeia Healthcare raised HKD 2,072 million (USD 267 m) from its global offering and will list on the Hong Kong Stock Exchange next Monday. In our...
519 Views